Xyra DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Virtual Booth

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

2 News #PharmaBuzz

media
2 News #PharmaBuzz

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

XYRA LLC is a private biopharmaceutical company dedicated to developing innovative therapies for cardiac rhythm disorders, specifically focusing on high unmet needs. The company's overarching goal is to elevate atrial fibrillation (AF) management to a level comparable to that of other prevalent cardiac conditions, such as hypertension and hypercholesterolemia. The approach involves the upward titration of effective drugs, guided by simple and widely available monitoring tools, to confirm compliance and assess the response to therapy. XYRA LLC aims to consistently improve outcomes for patients dealing with cardiac rhythm disorders.